Overview

NIraparib and Quality Of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.

Status:
Active, not recruiting

Trial end date:
2023-04-01

Target enrollment:

Participant gender:

Summary

This is a longitudinal, national, open, multi-centre phase IV study which will recruit up to 141 patients with ovarian cancer in late relapse treated with niraparib according to the labelling In France.

Phase:

Phase 4

Details

Lead Sponsor:

ARCAGY/ GINECO GROUP

Collaborator:

Tesaro, Inc.

Treatments:

Niraparib